期刊文献+

左旋卡尼汀对尿毒症血液透析患者微炎症状态的影响 被引量:11

Effects of L-carnitine on microinflammatory state in maintenance hemodialysis patients
下载PDF
导出
摘要 目的 探讨左旋卡尼汀对维持性血液透析患者微炎症状态的影响。方法 将42例维持性血液透析患者随机分为两组,试验组21例,对照组21例。每次透析后,试验组给予静脉注射左旋卡尼汀1g,对照组给予静脉注射生理盐水5ml,试验时间为3个月。结果 试验结束时,试验组IL-6、CRP含量明显降低,白蛋白、转铁蛋白水平升高,差异均具有统计学意义(P〈0.05),而对照组各项指标试验前后无明显改变。结论 左旋卡尼汀可降低维持性血液透析患者IL-6、CRP浓度,升高白蛋白、转铁蛋白浓度,改善患者营养及微炎症状态。 Objective To study the serum level changes of IL-6, CRP, albumin and transferrin in maintenance hemodialysis patients before and after L-carnitinc treatment. Method Forty-two stable maintenance hemodialysis patients in our dialysis center were enrolled. Patients were randomly divided into carnitine group and control group. In the treatment group, 1g L-carnitine was given intravenous to the patients at the end of each dialysis treatment, the patients in the control group were given normal saline, the trial lasted for 3 months. Results The IL-6,CRP,albumin and serum transferrin level singnificantly improved in treatment group(P〈0. 05). All the markers in the control group did not change throughout the trial. Conclusions L-carnitine can reduce serum levels of IL-6,CRP and increase albumin and transferrin and can improve the microinflammatory state in maintenance hemodialysis patients.
出处 《临床肾脏病杂志》 2005年第4期153-154,共2页 Journal Of Clinical Nephrology
关键词 左旋卡尼汀 尿毒症 血液透析 微炎症状态 药物治疗 L-carnitine Maintenance hemodialysis Microinflammatory state
  • 相关文献

参考文献9

  • 1Bergstrom J, Lindholm B, Malnutrition, et al. Cardiac disease and mortality: An intergrated point of view. Am J Kidney Dis,1998, 32: 834-841.
  • 2Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int, 1998,54 : 236-244.
  • 3Vescovo G, Ravara B, Gobbo V, et al. L-Camitine: a potential treatment for blocking apoptosis and preventing skeletal musule myopathy in heart failure. Am J Physiol Cell Physiol, 2002,283: 802-810.
  • 4Panichi V, Migliori M, De Pietro S, et al. C-reactive-protein as a marker of cytokine inflammation in uremic patients. Blood Purif, 2000, 18: 183-190.
  • 5Boenisch O, Ehmke KD, Heddergott A, et al. C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Am Soc Nephrol, 2002, 15 : 547-551.
  • 6Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int Suppl, 2000, 76:96-103.
  • 7Bergstrom J. Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn,2000, 104: 641-643.
  • 8Bergstrom J, Lindholm B, Lacsone Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patient? Semin Dial, 2000, 13: 163-175.
  • 9Winter BK, Fiskum G, Gallo LL, et al. Effects of L-camitine on serum triglyceride and cytokine levels in rat models of cachexia and septicshock. Br J Cancer, 1995, 72 : 1173-1179.

同被引文献62

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部